This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cardica Appoints Dr. Lee Swanstrom As Medical Director

Stocks in this article: CRDC

REDWOOD CITY, Calif., Oct. 19, 2011 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that Lee Swanstrom, M.D., F.A.C.S., has been named medical director of the company.

In this role, Dr. Swanstrom will assist Cardica in developing its clinical and launch strategy for its MicroCutter products and will train surgeons around the world on the use and benefits of the MicroCutter™ XPRESS™ 30, the first and only true multifire stapling device for laparoscopic surgery. In addition, he will provide strategic input on Cardica's pipeline of devices and their applications in various surgical and laparoscopic procedures.  

"Dr. Swanstrom is a widely-respected, world-renowned laparoscopic surgeon, who brings clinical expertise and an established rapport with surgeons across the country," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica. "We believe that his experience leading a highly sought-after fellowship program, and as a guest lecturer and hands-on skills instructor in courses around the world, will help strengthen our ability to reach and train surgeons on our planned MicroCutter product line."

Dr. Swanstrom is a board-certified surgeon with special interests in esophageal diseases, minimally invasive surgery and endoscopy. Dr. Swanstrom is a renowned researcher and innovator in the field of minimally invasive surgery. He is a Clinical Professor of Surgery at Oregon Health and Sciences University, serves as senior partner with The Oregon Clinic's Gastrointestinal & Minimally Invasive Surgery Division, is the president of the Foundation for Surgical Innovation and Education, and is also program director for postgraduate fellowships at the Providence Health System in Portland.  Additionally, he is very involved in international teaching, clinical and research positions and most recently was appointed Chief Innovations Officer at the University of Strasbourg's IHU (University Hospitals Institutes).

Dr. Swanstrom has published more than 200 articles in peer-reviewed journals, has written chapters in 45 books and holds seven patents for surgical/medical devices. Additionally, he is on the editorial boards of numerous medical/surgical journals and is currently Co-editor-in-Chief of Surgical Innovation. Dr. Swanstrom was appointed to the American Board of Surgery in 2010 and is active within the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), serving on the Executive Committee within SAGES in a variety of roles, including past president. He is also president of the Foundation for Surgical Innovation and Education. He is a founder and currently the Board Chairman of the Fellowship Council. He received his M.D. from Creighton University.

"In my daily life as a minimally invasive surgeon and surgical educator, I am constantly in search of the next best technologies -- ones that will further the promise of less invasive therapies for patients and that will make the practice of surgery easier and more efficient for both surgeon and patient," commented Dr. Swanstrom. "Cardica's MicroCutter platform, to me, is truly a paradigm shift in this direction. I am excited about the opportunity to be directly involved in the further development of this product line and in the introduction of it to a surgical market that is truly primed for such an innovation."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs